PEPS
/
REVIEW
Péptidos
Guías
Investigación
Herramientas
Vendedores
ES
EN
English
ES
Espanol
BR
Portugues
FR
Francais
KR
Korean
Registrarse
Péptidos
Guías
Investigación
Herramientas
Vendedores
Péptidos
/
Investigación
/
Tesamorelin
/
Investigación
Investigación: Tesamorelin
FDA-approved GHRH analog for HIV-associated lipodystrophy
Tesamorelin
Tesamorelin: a review of its use in the management of HIV-associated lipodystrophy
Drugs
2011
300
Review
Tesamorelin is the first and only approved treatment for reducing excess abdominal fat in HIV lipodystrophy, significantly reducing visceral adipose tissue over 26 weeks.
